Medications approved for people with diabetes and obesity have recently gotten a lot of media attention as a potential easy way to shed pounds. What are the physical and societal risks of using drugs like Ozempic and Mounjaro off label for weight loss, or for using these drugs as a quick weight-loss fix? Andy speaks with STAT reporter Elaine Chen and obesity medicine physician Ania Jastreboff about this new generation of drugs, who stands to benefit from them, and what to watch out for.

Keep up with Andy on Twitter and Post @ASlavitt.

Follow Elaine Chen and Ania Jastreboff on Twitter @elaineywchen and @AniaJastreboff.

Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.

Support the show by checking out our sponsors!

• Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/

Check out these resources from today’s episode: 

• Read extensive coverage by Elaine and her colleagues at STAT about the obesity drug revolution: https://www.statnews.com/category/the-obesity-revolution/
• Find vaccines, masks, testing, treatments, and other resources in your community: https://www.covid.gov/
• Order Andy’s book, “Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response”: https://us.macmillan.com/books/9781250770165

Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.

For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.